BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2020714)

  • 21. Acute delta hepatitis in Greek parenteral drug abusers.
    Tassopoulos NC; Koutelou MG; Papatheodoridis GV; Kalantzakis YS; Hatzakis AE
    Prog Clin Biol Res; 1993; 382():221-7. PubMed ID: 8502685
    [No Abstract]   [Full Text] [Related]  

  • 22. Viral hepatitis in HIV infection.
    Koziel MJ; Peters MG
    N Engl J Med; 2007 Apr; 356(14):1445-54. PubMed ID: 17409326
    [No Abstract]   [Full Text] [Related]  

  • 23. The natural history of chronic type B hepatitis in southern Italy: effect of HBV replication and of HDV infection.
    Craxì A; Di Marco V; Magrin S; Scalisi I; Vassallo R; Vinci M; Genova G; D'Amico G; Maisano S; Politi F
    Prog Clin Biol Res; 1987; 234():153-65. PubMed ID: 3628374
    [No Abstract]   [Full Text] [Related]  

  • 24. Interactions of HDV, HBV and HIV in chronic B and D infections and in reactivation of chronic D infection.
    Govindarajan S; Cassidy WM; Valinluck B; Redeker AG
    Prog Clin Biol Res; 1991; 364():207-10. PubMed ID: 2020697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of HD Ag and anti HD by radioimmunoassay in acute and chronic HBV infections in Tunisia.
    Ayed K; Gorgi Y; Pichoud C; Trepo C
    Prog Clin Biol Res; 1987; 234():441-2. PubMed ID: 3628409
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessment of delta virus infection in Venezuelan high-risk population for hepatitis B virus.
    Machado IV; Deibis L; Zabaleta M; Toro FI; Marino V; Ramirez JL; DePerez FE; Bianco NE
    Prog Clin Biol Res; 1991; 364():105-13. PubMed ID: 2020687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of serum anti-delta with intrahepatic HBV and HDV antigens in patients with chronic active hepatitis.
    Caporaso N; Di Sapio M; Del Vecchio-Blanco C; Coltorti M
    Prog Clin Biol Res; 1987; 234():137-44. PubMed ID: 3628372
    [No Abstract]   [Full Text] [Related]  

  • 28. New diagnostic assays for the detection of HDV-RNA and HDV-antibodies.
    Kos A; Bonelli F; Dubbeld M; Slachmuylders J; Palla M
    Prog Clin Biol Res; 1993; 382():325-8. PubMed ID: 8502698
    [No Abstract]   [Full Text] [Related]  

  • 29. A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study.
    Rosina F; Pintus C; Meschievitz C; Rizzetto M
    Hepatology; 1991 Jun; 13(6):1052-6. PubMed ID: 2050321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of IgM anti-HD during interferon therapy.
    Marinucci G; Hassan G; Di Giacomo C; Dato A; Barlattani A; Costa F
    Prog Clin Biol Res; 1993; 382():311-8. PubMed ID: 8502696
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of human immunodeficiency virus infection on cell-mediated immunity in chronic D hepatitis.
    Buti M; Esteban R; Español MT; Malagelada A; Jardi R; Rodriguez-Frias F; Roget M; Guardia J
    J Infect Dis; 1991 Jun; 163(6):1351-3. PubMed ID: 1674749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of hepatitis delta virus infection.
    Di Bisceglie AM; Negro F
    Hepatology; 1989 Dec; 10(6):1014-6. PubMed ID: 2491738
    [No Abstract]   [Full Text] [Related]  

  • 33. Prolonged alpha interferon therapy for chronic delta hepatitis: effect on liver histopathology.
    Kleiner D; Di Bisceglie AM; Axiotis CA; Hoofnagle JH
    Prog Clin Biol Res; 1993; 382():365-71. PubMed ID: 8502705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
    Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
    J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of early chronic delta hepatitis with lymphoblastoid alpha interferon: a pilot study.
    Marzano A; Ottobrelli A; Spezia C; Daziano E; Soranzo ML; Rizzetto M
    Ital J Gastroenterol; 1992; 24(3):119-21. PubMed ID: 1562748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term interferon-alpha treatment of children with chronic hepatitis delta: a multicentre study.
    Di Marco V; Giacchino R; Timitilli A; Bortolotti F; Crivellaro C; Calzia R; Iannuzzi C; Prestileo T; Vajro P; Nebbia G; Stringhi C; Rosina F; Biassoni D; Callea F; Rizzetto M; Craxi A
    J Viral Hepat; 1996 May; 3(3):123-8. PubMed ID: 8871870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-delta antibody in various HBsAg positive Argentine populations.
    Fay O; Tanno H; Palazzi J; Gatti H
    Prog Clin Biol Res; 1987; 234():517-8. PubMed ID: 3628422
    [No Abstract]   [Full Text] [Related]  

  • 38. Suppression of hepatitis delta virus by concurrent hepatitis C virus superinfection in patients with chronic hepatitis B virus infection.
    Liaw YF; Hsieh SY; Chien RN; Chen TJ; Sheen IS; Chu CM
    Prog Clin Biol Res; 1993; 382():229-34. PubMed ID: 8502686
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of the histological and serological parameters of patients with hepatitis delta virus in active and inactive hepatitis B virus carriers.
    Shaikh S; Ram DB; Tanveer S; Talpur A
    J Coll Physicians Surg Pak; 2014 Feb; 24(2):97-100. PubMed ID: 24491002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of chronic hepatitis delta virus (HDV) infection with human lymphoblastoid alpha interferon.
    Farci P; Karayiannis P; Brook MG; Smedile A; Lai ME; Balestrieri A; Saldanha JA; Monjardino J; Gerin J; Thomas HC
    Q J Med; 1989 Nov; 73(271):1045-54. PubMed ID: 2623137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.